Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mahaffey

Showing results (161-170 of 627) with videos related to

Pageof 63
Sort By:
American Heart Journal|May 16, 2016
Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryAnna Gundlund, Emil Loldrup Fosbøl, Sunghee Kim, et al.
Critical Care Medicine|June 14, 2013
The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarctionSean van Diepen, John P Vavalle, L Kristin Newby, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 18, 2015
Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled TrialGreg Fulcher, David R Matthews, Vlado Perkovic, et al.
American Heart Journal|July 31, 2013
Results of a reevaluation of cardiovascular outcomes in the RECORD trialKenneth W Mahaffey, Gail Hafley, Sheila Dickerson, et al.
Trials|April 11, 2020
Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated eventsAlexander C Fanaroff, Ghazala Haque, Betsy Thomas, et al.
Circulation|March 13, 2018
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS ProgramKarin Rådholm, Gemma Figtree, Vlado Perkovic, et al.
JAMIA Open|February 8, 2023
Design and development of a digital shared decision-making tool for stroke prevention in atrial fibrillationJulio C Nunes, Tina Baykaner, Krishna Pundi, et al.
European Journal of Clinical Investigation|May 28, 2011
Determinants of plasma vitamin D levels in patients with acute coronary syndromesGabriella Rodriguez, Aijing Z Starr, Grazyna Z Czernuszewicz, et al.
Journal of the American College of Cardiology|April 25, 2009
Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary interventionPaul W Armstrong, Yuling Fu, Cynthia M Westerhout, et al.
Journal of the American College of Cardiology|November 13, 2001
A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trialW B Batchelor, K W Mahaffey, P B Berger, et al.
Pageof 63

Showing results (161-170 of 627) with videos related to

Sort By:
Pageof 63
American Heart Journal|May 16, 2016
Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryAnna Gundlund, Emil Loldrup Fosbøl, Sunghee Kim, et al.
Critical Care Medicine|June 14, 2013
The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarctionSean van Diepen, John P Vavalle, L Kristin Newby, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 18, 2015
Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled TrialGreg Fulcher, David R Matthews, Vlado Perkovic, et al.
American Heart Journal|July 31, 2013
Results of a reevaluation of cardiovascular outcomes in the RECORD trialKenneth W Mahaffey, Gail Hafley, Sheila Dickerson, et al.
Trials|April 11, 2020
Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated eventsAlexander C Fanaroff, Ghazala Haque, Betsy Thomas, et al.
Circulation|March 13, 2018
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS ProgramKarin Rådholm, Gemma Figtree, Vlado Perkovic, et al.
JAMIA Open|February 8, 2023
Design and development of a digital shared decision-making tool for stroke prevention in atrial fibrillationJulio C Nunes, Tina Baykaner, Krishna Pundi, et al.
European Journal of Clinical Investigation|May 28, 2011
Determinants of plasma vitamin D levels in patients with acute coronary syndromesGabriella Rodriguez, Aijing Z Starr, Grazyna Z Czernuszewicz, et al.
Journal of the American College of Cardiology|April 25, 2009
Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary interventionPaul W Armstrong, Yuling Fu, Cynthia M Westerhout, et al.
Journal of the American College of Cardiology|November 13, 2001
A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trialW B Batchelor, K W Mahaffey, P B Berger, et al.
Pageof 63